HVO vs. VRP, ARIX, BVXP, CIR, 4BB, AVCT, TILS, VSN, SCLP, and MPH
Should you be buying hVIVO stock or one of its competitors? The main competitors of hVIVO include Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Bioventix (BVXP), Circassia Group (CIR), 4basebio (4BB), Avacta Group (AVCT), Tiziana Life Sciences (TILS), Verseon (VSN), Scancell (SCLP), and Mereo BioPharma Group plc (MPH.L) (MPH). These companies are all part of the "biotechnology" industry.
hVIVO vs. Its Competitors
hVIVO (LON:HVO) and Verona Pharma plc (VRP.L) (LON:VRP) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.
Verona Pharma plc (VRP.L) received 102 more outperform votes than hVIVO when rated by MarketBeat users. However, 70.22% of users gave hVIVO an outperform vote while only 64.67% of users gave Verona Pharma plc (VRP.L) an outperform vote.
Given Verona Pharma plc (VRP.L)'s higher possible upside, analysts plainly believe Verona Pharma plc (VRP.L) is more favorable than hVIVO.
hVIVO has higher revenue and earnings than Verona Pharma plc (VRP.L). Verona Pharma plc (VRP.L) is trading at a lower price-to-earnings ratio than hVIVO, indicating that it is currently the more affordable of the two stocks.
hVIVO has a net margin of 25.96% compared to Verona Pharma plc (VRP.L)'s net margin of 0.00%. hVIVO's return on equity of 47.93% beat Verona Pharma plc (VRP.L)'s return on equity.
In the previous week, hVIVO had 1 more articles in the media than Verona Pharma plc (VRP.L). MarketBeat recorded 1 mentions for hVIVO and 0 mentions for Verona Pharma plc (VRP.L). hVIVO's average media sentiment score of 0.75 beat Verona Pharma plc (VRP.L)'s score of 0.00 indicating that hVIVO is being referred to more favorably in the media.
34.9% of hVIVO shares are owned by institutional investors. 14.0% of hVIVO shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
hVIVO beats Verona Pharma plc (VRP.L) on 13 of the 15 factors compared between the two stocks.
Get hVIVO News Delivered to You Automatically
Sign up to receive the latest news and ratings for HVO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:HVO) was last updated on 6/13/2025 by MarketBeat.com Staff
